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Abstract
Objective: This study was carried out to evaluate whether the type of pump used for cardiopulmonary bypass (CPB; roller vs. centrifugal)
can affect mortality or the neurological outcomes of adult cardiac surgery patients. Methods: Between 1994 and June 1999, 4000 consecutive
patients underwent coronary and/or valve surgery at our hospital; of these, 2213 (55.3%) underwent surgery with centrifugal pump use, while
1787 (44.7%) were operated on with a roller pump. The effect of the type of the pump and of 36 preoperative and intraoperative risk factors
for perioperative death, permanent neurological de®cit and coma were assessed using univariate and multivariate analyses. Results: The
overall in-hospital mortality rate was 2.2% (88/4000), permanent neurological de®cit occurred in 2.0% (81/4000) of patients, and coma in
1.3% (52/4000). There was no difference in hospital mortality between patients operated with the use of centrifugal pumps and those operated
with roller pumps (50/2213 (2.3%) vs. 38/1787 (2.1%); P  0:86). On the other hand, patients who underwent surgery with centrifugal
pumps had lower permanent neurological de®cit (34/2213, (1.5%) vs. 47/1787 (2.6%); P  0:020) and coma (20/2213 (0.9%) vs. 32/1787
(1.8%); P  0:020) rates than patients operated with roller pumps. Multivariate analysis showed CPB time, previous TIA and age as risk
factors for permanent neurological de®cit, while centrifugal pump use emerged as protective. Multivariate risk factors for coma were CPB
time, previous vascular surgery and age, while centrifugal pump use was protective. Conclusions: Centrifugal pump use is associated with a
reduced rate of major neurological complications in adult cardiac surgery, although this is not paralleled by a decrease in in-hospital
mortality. q 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Neurological injury is one of the most debilitating
complications after adult cardiac surgery performed using
cardiopulmonary bypass (CPB). Despite a continuous trend
towards a decline in overall mortality in adult cardiac
surgery, an increase in the average age of patients under-
going cardiac surgery has resulted in a substantial increase
in serious adverse neurological events, and in the proportion
of related in-hospital deaths[1,2].
Previous studies have assessed the effect of CPB on
neurological outcomes in adult patients undergoing cardiac
surgery[3±10]; however, little information exists on whether
the type of the pump used for CPB (roller vs. centrifugal)
can affect the neurological outcomes of adult patients under-
going cardiac surgery.
The aim of this study was to evaluate risk factors for
perioperative mortality and adverse neurological outcomes,
with special emphasis on the role of using a roller or centri-
fugal pump for perfusion.
2. Patients and methods
We have retrospectively reviewed the charts of 4000
consecutive patients who, during the period of January
1994±June 1999, underwent coronary and/or valve surgery
with the use of CPB at our hospital. Patients who had addi-
tional procedures performed (LV aneurysmectomy, carotid
endarterectomy, ascending aorta replacement) were
excluded from the study.
2.1. Surgical procedure
On the morning of surgery, patients received their usual
dose of antianginal drugs, and 2±5 mg morphine and 1 mg
atropine as premedication. All patients received a standard
moderate dose of fentanyl and benzodiazepine anesthesia,
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which was induced by the administration of sodium thio-
pental (3 mg/kg), fentanyl (0.75 mg/kg), succinylcholine (1
mg/kg), diazepam (10 mg) and pancuronium bromide (0.1
mg/kg). After endotracheal intubation, patients were venti-
lated to normocapnia with an oxygen and air mixture.
Boluses of fentanyl (with or without droperidol), diazepam
and pancuronium bromide were given when necessary.
Cefuroxime (2 g) was given intravenously for infection
prophylaxis. A radial artery catheter and a ¯ow-directed
pulmonary artery catheter were inserted for hemodynamic
measurements. The extracorporeal circuit consisted of a
roller pump (CAPS HLM; Stockert Instruments, Munich,
Germany) or a centrifugal pump (Biomedicus BioPump;
Medtronic, Milan, Italy), hollow ®ber oxygenator with inte-
grated heat exchanger, arterial ®lter, cardiotomy reservoir
and polyvinyl tubing system. In all cases, an `open' system
was used for perfusion.
The type of pump was chosen based on a consensus
between the surgeon and anesthesiologist, with preference
given to the centrifugal pump for CPB times which were
expected to be longer (.100 min).
No heparin bonding was used in the perfusion tubing or
oxygenator. The extracorporeal circuit was primed with
1500 ml electrolyte solution and 5000 IU bovine lung
heparin (Liquemin; Roche, Italy).
After systemic heparinization (300 U/kg), CPB was
initiated with cannulas placed in the ascending aorta and
right atrium. The activated clotting time was kept at
$400 s with additional heparin.
The pump ¯ow was non-pulsatile in all operations. The
¯ow rate was maintained at 2.4 l/min per m2 during cooling
and rewarming phases, and at 2.0 l/min per m2 during stable
hypothermia. The mean arterial pressure (MAP) during
CPB was maintained between 60 and 90 mmHg, with
CPB ¯ows set as previously described, and vasoactive
drugs were used to maintain the MAP in the desired
range: if the MAP increased above the desired range, and
was unresponsive to fentanyl or diazepam, sodium nitropor-
usside was started, but if the MAP fell below the desired
range, norepinephrine, boluses or continuous infusion were
added. Patients were cooled to 28±308C. CPB ¯ows and
pressures were downloaded from the monitor and recorded
every 5 min during perfusion. Any signi®cant modi®cation
of the perfusion pattern during 5 min time intervals was also
recorded by the perfusionist.
For myocardial protection, patients received a ®rst dose
(1000 cc) of cool (48C) antegrade and retrograde high-potas-
sium cold crystalloid cardioplegia (St. Thomas Hospital
Cardioplegic solution containing 110 mmol/l NaCl, 16
mmol/l KCl, 16 mmol/l MgCl2, 1.2 mmol/l CaCl2 and 10
mmol/l NaHCO3) just after aortic cross-clamping, which
was repeated (250 ml retrograde) at every 20 min of the
aortic cross-clamp time. Disturbances in the acid±base
balance were appropriately treated, and the acid±base equi-
librium was maintained by the alpha-STAT method. The
hematocrit during CPB was maintained at 18±25%.
After termination of CPB, heparin was antagonized with
protamine sulfate at a 1:1 ratio (3 mg/kg). If necessary,
inotropic support was given when patients were weaned
from CPB. Autologous blood and residual volume from
the extracorporeal circuit were infused into the patient
when volume supplementation was necessary.
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Table 1
Preoperative variables of the study populationa
Age at intervention (years) 64 (57±70)
Preoperative weight (kg) 76 (64±80)
Body surface area (m2) 1.8 (1.7±1.9)
Male sex 2885/4000 (72)
History of hypertension 2142/4000 (54)
History of smoking 1610/4000 (40)
Previous myocardial infarction 1685/4000 (42)
Previous cardiac surgery 288/4000 (7.2)
Previous vascular surgery 152/4000 (3.8)
Insulin-dependent diabetes mellitus 103/4000 (2.6)
Peripheral vascular disease 414/4000 (10)
History of asthma 66/4000 (1.7)
History of COPD 344/4000 (8.6)
History of heart failure 535/4000 (13)
Previous TIA 271/4000 (6.8)
Previous RIND 43/4000 (1.1)
Previous stroke 147/4000 (3.7)
Previous neurological events 448/4000 (11)
Blood hematocrit (%) 39 (36±42)
Blood creatinine level (mg/dl) 1.1 (9±1.2)
Blood creatinine level (.2 mg/dl) 57/4000 (1.4)
Sinus rhythm at preoperative EKG 3380/4000 (85)
a Numbers in parentheses represent either percentage values or 25th and
75th percentiles.
Table 2






CABG 1 VR 183/4000 (4.5)
Use of centrifugal pump for CPB 2213/4000 (55)
Aortic cross-clamp time (min) 79 (61±101)
CPB time (min) 109 (88±136)
Need to perform a circulatory arrest (.5 min) 17/4000 (0.4)
CPB ¯ow during the cooling phase (l/min per m2) 2.3 (2.1±2.4)
Blood pressure during the cooling phase (mmHg) 70 (60±80)
CPB ¯ow during the stable hypothermia phase
(l/min per m2)
2 (1.8±2.2)
Blood pressure during the stable hypothermia phase
(mmHg)
75 (65±85)
CPB ¯ow during the rewarming phase (l/min per m2) 2.3 (2.2±2.4)
Blood pressure during the rewarming phase (mmHg) 70 (65±80)
Minimum esophageal temperature reached (8C) 29.2 (27.6±30.0)
Minimum rectal temperature reached (8C) 30.6 (29.6±31.5)
CPB ¯ow during the entire bypass time
(l/min per m2)
2.2 (2.1±2.3)
Blood pressure during the entire bypass time (mmHg) 73 (67±79)
a Numbers in parentheses represent either percentage values or 25th and
75th percentiles.
After surgery, patients were admitted to the intensive care
unit (ICU) and treated according to a standardized protocol.
The MAP was kept at 70±90 mmHg, heart rate at 70±90
beats/min, and the cardiac index was maintained at greater
than 2.0 l/min per m2. Inotropic support was administered
when necessary. Patients were ventilated to normocapnia,
and an arterial oxygen tension of 80 mmHg with continuous
positive-pressure ventilation until extubation was main-
tained according to the ICU regimen. Basic ¯uid adminis-
tration consisted of 0.9% NaCl and polygelatine. Packed
erythrocytes were infused when the hematocrit was ,18%
during CPB and ,24% in the ICU. When their cardio-
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Table 3
Preoperative variables of the study population by the type of pumpa
Variable Centrifugal pump Roller pump P
Age at intervention (years) 64 (57±70) 64 (56±70) 0.25
Preoperative weight (kg) 72 (64±80) 71 (64±80) 0.086
Body surface area (m2) 1.8 (1.7±1.9) 1.8 (1.7±1.9) 0.25
Male sexb 73 (1614/2213) 71 (1271/1787) 0.21
History of hypertensionb 53 (1176/2213) 54 (966/1787) 0.58
History of smokingb 41 (915/2213) 39 (695/1787) 0.12
Previous myocardial infarctionb 45 (984/2213) 39 (701/1787) , 0.001
Previous cardiac surgeryb 8.6 (190/2213) 5.5 (98/1787) , 0.001
Previous vascular surgeryb 3.7 (81/2213) 4.0 (71/1787) 0.66
Insulin-dependent diabetes mellitusb 3.1 (68/2213) 2.0 (35/1787) 0.035
Peripheral vascular diseaseb 11 (239/2213) 9.8 (175/1787) 0.32
History of asthmab 1.7 (37/2213) 1.6 (29/1787) 0.99
History of COPDb 8.2 (181/2213) 9.1 (163/1787) 0.31
History of heart failureb 12 (275/2213) 15 (260/1787) 0.056
Previous TIAb 7.7 (170/2213) 5.7 (101/1787) 0.013
Previous RINDb 1.1 (25/2213) 1.0 (18/1787) 0.82
Previous strokeb 4.2 (94/2213) 3.0 (53/1787) 0.040
Previous neurological eventsb 13 (285/2213) 9.1 (163/1787) , 0.001
Blood hematocrit (%) 40 (36±43) 39 (35±42) , 0.001
Blood creatinine level (mg/dl) 1.1 (0.9±1.2) 1.1 (0.9±1.2) 0.23
Blood creatinine level (.2 mg/dl)b 1.5 (33/2213) 1.3 (24/1787) 0.78
Sinus rhythm at preoperative EKGb 84 (1859/2213) 85 (1521/1787) 0.35
a Centrifugal vs. roller.
b Figures represent either percentage values followed by the proportion in parentheses or median followed by 25th and 75th percentile in parentheses.
Table 4
Operative variables of the study population by the type of pumpa
Variable Centrifugal pump Roller pump P
Type of surgery
CABGb 68 (1513/2213) 67 (1191/1787) 0.30
AVRb 12 (264/2213) 12 (213/1787)
MVRb 11 (232/2213) 10 (184/1787)
DVRb 5 (107/2213) 6 (113/1787)
CABG 1 VRb 4 (97/2213) 5 (86/1787)
Aortic cross-clamp time (min) 81 (62±1049) 76 (60±98) , 0.001
CPB time (min) 112 (90±140) 106 (85±131) , 0.001
Need to perform a circulatory arrest (.5 min)b 0.7 (16/2213) 0.4 (7/1787) 0.24
CPB ¯ow during the cooling phase (l/min) 2.3 (2.2±2.4) 2.3 (2.2±2.4) , 0.001
Blood pressure during the cooling phase (mmHg) 75 (65±80) 70 (60±75) , 0.001
CPB ¯ow during the stable hypothermia phase (l/min per m2) 2.0 (1.8±2.1) 2.0 (1.8±2.2) , 0.001
Blood pressure during the stable hypothermia phase (mmHg) 80 (70±85) 70 (60±80) , 0.001
CPB ¯ow during the rewarming phase (l/min per m2) 2.3 (2.2±2.4) 2.3 (2.2±2.5) , 0.001
Blood pressure during the rewarming phase (mmHg) 75 (65±80) 70 (65±75) , 0.001
Minimum esophageal temperature reached (8C) 29.5 (28.5±30.1) 28.3 (27.1±29.8) , 0.001
Minimum rectal temperature reached (8C) 30.8 (30.0±31.6) 30.4 (29.3±31.5) , 0.001
CPB ¯ow during the entire bypass time (l/min per m2) 2.2 (2.0±2.3) 2.2 (2.1±2.4) , 0.001
Blood pressure during the entire bypass time (mmHg) 75 (69±82) 70 (63±77) , 0.001
a Centrifugal vs. roller.
b Figures represent either percentage values followed by the proportion in parentheses or median followed by 25th and 75th percentile in parentheses.
respiratory condition had stabilized, patients were trans-
ported to the ward for further recovery.
2.2. Statistical analysis
The data are presented as medians (25 and 75% percen-
tiles in brackets) for continuous variables or percentages for
categorical variables. A commercial statistical package
(SPSS for Windows Version 8.0; SPSS, Inc., Chicago, IL)
was used for data analysis.
Thirty-seven preoperative and operative variables,
including the type of pump employed for CPB (roller vs.
centrifugal; Tables 1 and 2) were assessed for their possible
effect on the occurrence of the following outcomes, which
were de®ned as follows:
In-hospital mortality: any death occurring within 30 days
after surgery, or anytime before discharge of the
patient from the hospital;
Permanent neurological de®cit: a central neurological de®cit
persisting .72 h;
Coma: unresponsiveness .24 h in the absence of sedation.
All continuous variables were ®rst tested individually
(univariate sense) with the non-parametric Mann±Whitney
test, while categorical variables were explored by the Chi-
square (Yates' continuity correction) or the Fisher's exact
test when indicated.
The factors which were at least marginally signi®cant
(P # 0:2) by univariate analysis were included into a multi-
variable forward stepwise logistic regression model. The
multivariate odds ratio (OR) for each independent variable
in the ®nal regression models and 95% con®dence intervals
were also computed. The P value for entry of a covariate
into the model was set at a signi®cance level 0.05, while the
P value for the removal of a covariate was ®xed at the 0.1
signi®cance level. Every multivariable model was tested for
reliability with the Hosmer±Lemeshow statistic [11].
3. Results
3.1. Patient population
The preoperative and operative clinical features of the
patient population are reported in Tables 1 and 2, respec-
tively. Brie¯y, the median age was 65, 72% of the patients
were male, 3.7% had had a previous stroke, 7.2% were
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Table 5
Signi®cant or borderline univariate risk factors for in-hospital death
Variable In-hospital deaths vs. hospital survivors P value
Age at intervention (years) 67 (61±71) vs. 64 (57±70) 0.026
Preoperative weight (kg) 65 (55±76) vs. 72 (64±80) , 0.001
Body surface area (m2) 1.7 (1.6±1.9) vs. 1.8 (1.7±1.9) 0.001
Male sexa 61 (54/88) vs. 72 (2831/3912) 0.031
Previous cardiac surgerya 22 (19/88) vs. 6.9 (269/3912) , 0.001
History of COPDa 17 (15/88) vs. 8.4 (329/3912) 0.008
History of heart failure 24 (21/88) vs. 13 (514/3912) 0.006
Previous RINDa 3.4 (3/88) vs. 1.0 (40/3912) 0.1
Previous strokea 8.0 (7/88) vs. 3.6 (140/3912) 0.061
Blood hematocrit (%) 36 (33±40) vs. 39 (36±42) , 0.001
Blood creatinine level (mg/dl) 1.1 (1.0±1.5) vs. 1.1 (0.9±1.2) 0.077
Blood creatinine level (.2 mg/dl)a 6.8 (6/88) vs. 1.3 (51/3912) , 0.001
Sinus rhythm at preoperative EKGa 74 (65/88) vs. 85 (3315/3912) 0.008
Aortic cross-clamp time (min) 95 (74±131) vs. 78 (61±100) , 0.001
CPB time (min) 149 (115±202) vs. 109 (87±135) , 0.001
CABG operationa 58 (51/88) vs. 68 (2653/3912) 0.066
VR 1 CABG operationa 13 (11/88) vs. 4.4 (172/3912) , 0.001
Need to perform a circulatory arrest .5 mina 2.3 (2/88) vs. 0.4 (15/3912) 0.062
CPB ¯ow during the cooling phase (l/min per m2) 2.3 (2.1±2.4) vs. 2.3 (2.2±2.4) , 0.001
CPB ¯ow during the stable hypothermia phase (l/min per m2) 2 (1.8±2.3) vs. 2 (1.8±2.2) 0.18
Blood pressure during the stable hypothermia phase (mmHg) 75 (60±80) vs. 75 (65±85) 0.17
CPB ¯ow during the rewarming phase (l/min per m2) 2.3 (2.2±2.5) vs. 2.3 (2.1±2.5) 0.010
Minimum esophageal temperature reached (8C) 28.4 (27.0±30.0) vs. 29.2 (27.6±30.0) 0.001
Minimum rectal temperature reached (8C) 30.2 (28.7±31.1) vs. 30.6 (29.6±31.5) 0.021
a Figures represent changes percentage values followed by the proportion in parentheses as per Tables 3 1 4.
Table 6
Results of multivariate logistic regression for in-hospital deatha
Variable OR 95% CI P value
CPB time (min) 1.015 1.011±1.394 0.0001
Previous cardiac surgery 1.7 1.2±2.3 0.0026
Blood creatinine level .2 mg/dl 2.0 1.1±3.6 0.0189
Blood hematocrit (%) 0.94 0.88±0.99 0.0215
a Hosmer±Lemeshow goodness-of-®t-test, x28  7:01; P  0:54.
redos, 13% had a history of heart failure, 68% underwent
coronary artery bypass grafting, 55% underwent surgery
with the use of a centrifugal pump, and the median CPB
time was 110 min.
The clinical variables of patients who underwent surgery
using centrifugal or roller pumps are reported in Tables 3
and 4. Regarding preoperative variables, the two groups of
patients were similar in age, body surface area, gender,
history of hypertension, preoperative pulmonary, and renal
status; on the other hand, patients who underwent surgery
with the use of a centrifugal pump had a higher incidence of
previous myocardial infarction, insulin-dependent diabetes
mellitus, were more frequently redos, and had a higher inci-
dence of previous transitory ischemic attack (TIAs), strokes,
and overall neurological events. The analysis of the opera-
tive variables showed similar frequencies in the different
types of surgery, as well as in the need to perform a circu-
latory arrest, while aortic cross-clamp and CPB times were,
as expected, longer in cases using a centrifugal pump.
Finally, there were statistically signi®cant differences in
perfusion pressures, ¯ows and temperatures between roller
and centrifugal pumps: pump ¯ows were slightly lower in
cases of centrifugal pump use, while pressures and tempera-
tures were slightly higher; however, in no case did the
differences between the two groups in CPB-related vari-
ables exceed a 10% variation, and this was reported as
less than 5% in most of the comparisons.
3.2. In-hospital mortality
The overall in-hospital mortality rate of this series of
patients was 2.2% (88/4000); there was no difference
between hospital mortalities based on the type of pump,
those being 2.3 (50/2213) and 2.1% (38/1787) for patients
who were operated on using centrifugal and roller pumps,
respectively (P  0:860). The univarate risk factors for
in-hospital death are reported in Table 5; and the multivari-
ate risk factors for in-hospital death were longer CPB times,
previous cardiac surgery, blood creatinine levels . 2 mg/dl,
and lower blood hematocrit levels (Table 6).
The interactions among in-hospital mortality, neurologi-
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Table 7
Interaction among in-hospital mortality, neurological outcomes, and type of
pump
In-hospital mortality Total P
Yes No %
All patients (n 4000)
Perioperative coma
Yes 24 28 46 52
No 64 3884 1.6 3948
Total 88 3912 4000 , 0.001
Perioperative permanent neurological de®cit
Yes 14 67 17 81
No 74 3845 2.0 3919
Total 88 3912 4000 , 0.001
Patients operated with centrifugal pump use (n 2213)
Perioperative coma
Yes 10 10 50 20
No 40 2153 1.9 2193
Total 50 2163 2213 , 0.001
Perioperative permanent neurological de®cit
Yes 7 27 21 34
No 43 2136 2.0 2179
Total 50 2163 2213 , 0.001
Patients operated with roller pump use (n 1787)
Perioperative coma
Yes 14 18 44 32
No 24 1731 1.4 1755
Total 38 1749 1787 , 0.001
Perioperative permanent neurological de®cit
Yes 7 40 1.5 47
No 31 1709 1.8 1740
Total 38 1749 1787 , 0.001
Table 8
Signi®cant or borderline univariate risk factors for perioperative permanent neurological de®cit
Variable Perioperative neurological de®cit vs.
no perioperative neurological de®cit
P value
Age at intervention (years) 67 (63±72) vs. 64 (57±70) 0.002
Previous vascular surgerya 8.6 (7/81) vs. 3.7 (145/3919) 0.045
Peripheral vascular diseasea 17 (14/81) vs. 10 (400/3919) 0.059
Previous TIAa 20 (16/81) vs. 6.5 (255/3919) , 0.001
Blood hematocrit (%) 38 (35±40) vs. 39 (36±42) 0.020
Blood creatinine level (mg/dl) 1.2 (1.0±1.4) vs. 1.1 (0.9±1.2) 0.002
Blood creatinine level .2 mg/dla 4.9 (4/81) vs. 1.4 (53/3919) 0.026
Sinus rhythm at preoperative EKGa 75 (61/81) vs. 85 (3319/3919) 0.031
Use of centrifugal pump for CPBa 42 (34/81) vs. 56 (2179/3919) 0.020
Aortic cross-clamp time (min) 85 (67±105) vs. 79 (61±101) 0.070
CPB time (min) 122 (91±159) vs. 109 (88±135) 0.009
Need to perform a circulatory arrest .5 mina 2.5 (2/81) vs. 0.4 (15/3919) 0.002
Minimum esophageal temperature reached (8C) 29.0 (27.2±29.8) vs. 29.2 (27.6±30.0) 0.054
Minimum rectal temperature reached (8C) 30.4 (28.9±31.1) vs. 30.6 (29.6±31.6) 0.005
a Figures represent either percentage values followed by the proportion in parentheses or median followed by 25th and 75th percentiles in parentheses.
cal outcomes and pump type are reported in Table 7.
Patients who showed a permanent neurological de®cit or
coma had higher in-hospital mortality rates compared with
patients free from these complications; similar results were
obtained from separate analysis of patients operated with
centrifugal or roller pumps.
3.3. Analysis of the risk factors for the occurrence of
perioperative permanent neurological de®cit
The signi®cant or marginally signi®cant univariate risk
factors for perioperative permanent neurological de®cit are
reported in Table 8. Patients who underwent surgery with
the use of a centrifugal pump had a permanent neurological
de®cit rate of 1.5% (34/2213), while the incidence of this
complication in patients who were operated with a roller
pump was 2.6% (47/1787; P  0:020). Multivariable logis-
tic regression analysis identi®ed longer CPB times, previous
TIAs and increasing age as multivariate risk factors for
perioperative permanent neurological de®cit, while the use
of a centrifugal pump for CPB emerged as a protective
factor (Table 9).
3.4. Analysis of the risk factors for the occurrence of
perioperative coma
The signi®cant or marginally signi®cant univariate risk
factors for perioperative coma are reported in Table 10.
Regarding the type of pump used for perfusion, patients
who underwent surgery with a centrifugal pump had a peri-
operative coma rate of 0.9% (20/2213), while the incidence
of coma in patients who were operated using a roller pump
was 1.8% (32/1787; P  0:020). Multivariable logistic
regression analysis identi®ed longer CPB times, previous
vascular surgery and increasing age as independent risk
factors for the occurrence of perioperative coma, while
centrifugal pump use resulted as protective (Table 11).
4. Discussion
The continuous improvement of techniques in adult
cardiac surgery has substantially reduced the morbidity
and mortality in cardiac operations requiring CPB. Despite
these advances, however, adverse neurological and neuro-
behavioral outcomes continue to occur, at perhaps an
increased frequency, due to the progressive aging of the
population of patients undergoing cardiac surgery [1,2].
To date, several studies assessed the effect of CPB-related
variables on neurological outcomes in adult patients under-
going cardiac surgery; in particular, it could be demon-
strated that longer CPB times [4,5] and severity of
ascending aorta atherosclerosis [4,8] were strong predictors
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Table 9
Results of multivariate logistic regression for perioperative permanent
neurological de®cita
Variable OR 95% CI P value
CPB time (min) 1.007 1.004±1.010 0.0001
Previous TIA 2.5 1.5±4.4 0.0067
Age at intervention (years) 1.038 1.014±1.062 0.0116
Use of centrifugal pump for CPB 0.57 0.38±0.87 0.0363
a Hosmer±Lemeshow goodness-of-®t-test, x28  8:86; P  0:35.
Table 10
Signi®cant or borderline univariate risk factors for perioperative coma
Variable Perioperative coma vs. no perioperative
coma
P value
Age at intervention (years) 69 (64±72) vs. 64 (57±70) 0.001
Preoperative weight (kg) 68 (60±72) vs. 72 (64±80) 0.001
Body surface area (m2) 1.7 (1.6±1.8) vs. 1.8 (1.7±1.9) 0.001
Previous cardiac surgerya 15 (8/52) vs. 7.1 (280/3948) 0.043
Previous vascular surgerya 13 (7/52) vs. 3.7 (145/3948) , 0.001
Peripheral vascular diseasea 21 (11/52) vs. 10 (403/3948) 0.019
Previous RINDa 5.8 (3/52) vs. 1.0 (43/3948) 0.009
Previous strokea 12 (6/52) vs. 3.6 (141/3948) 0.008
Blood hematocrit (%) 35 (33±39) vs. 39 (36±42) , 0.001
Blood creatinine level (mg/dl) 1.2 (1.0±1.5) vs. 1.1 (0.9±1.2) , 0.001
Sinus rhythm at preoperative EKGa 63 (33/52) vs. 85 (3347/3948) , 0.001
Use of centrifugal pump for CPBa 38 (20/52) vs. 56 (2193/3948) 0.020
Aortic cross-clamp time (min) 91 (76±126) vs. 79 (61±100) 0.005
CPB time (min) 148 (111±181) vs. 109 (88±135) , 0.001
Need to perform a circulatory arrest .5 mina 5.8 (3/52) vs. 0.4 (14/3948) 0.013
Blood pressure during the stable hypothermia phase (mmHg) 70 (60±80) vs. 75 (65±85) 0.030
Blood pressure during the rewarming phase (mmHg) 70 (65±75) vs. 70 (65±80) 0.024
Minimum esophageal temperature reached (8C) 28.2 (27.0±29.3) vs. 29.2 (27.6±30.0) 0.002
Minimum rectal temperature reached (8C) 30.0 (28.4±31.1) vs. 30.6 (29.6±31.5) 0.005
a Figures outside either parentheses represent percentage values or median followed by 25th and 75th percentiles in parentheses.
of perioperative neurological complications, while lack of
arterial line ®ltration [9,12] and pH-stat acid±base manage-
ment [10] could also increase the occurrence of postopera-
tive central nervous system dysfunction. On the other hand,
the possible effects of other CPB variables are still being
debated, and the roles of temperature management
(normothermic vs. moderately hypothermic perfusion),
mean arterial pressure levels during CPB and type of perfu-
sion (pulsatile vs. non-pulsatile) in affecting neurological
complication rates have not yet been completely de®ned
[13].
Centrifugal pumps have been widely used as the main
pump in adult cardiac surgery, and are considered by
some authors to be superior to the traditionally used roller
pumps because of less blood trauma [14], reduced activation
of the coagulation cascade [15] and improved biocompat-
ibility [16], even if some of the studies could not document
any signi®cant bene®ts in terms of hemolysis [17], platelet
damage [18] or immune response [19]; in addition, some
recent evidence could document an increased in¯ammatory
response to CPB in cases using centrifugal pumps [20,21].
There is less information, however, on the effect of the
use of this kind of pump on clinical endpoints, and the
effects on neurological function are not well established
yet; even if centrifugal pumps have been shown to generate
fewer microemboli than roller pumps [22], it was recently
demonstrated that, for CPB times of less than 90 min, centri-
fugal pumps did not decrease serum S100b release, a
marker for cerebral injury, compared with roller pumps
[23]. In addition, only one paper, by Klein and colleagues,
has previously evaluated the effect of centrifugal and roller
pumps used for CPB on many different clinical outcomes,
documenting a reduced rate of neurological complications
when a centrifugal pump was used for perfusion; but no
additional information was given about the criteria used to
de®ne neurological complications in this paper [24].
The aim of our study was then to retrospectively review
the data concerning adult patients who underwent coronary
and/or valve surgery at our hospital during a 5.5-year period
(1994±June 1999); during that period, in fact, both types of
pump (roller and centrifugal) were used at our hospital at the
same time by the same team of surgeons, anesthesiologists
and perfusionists. Our study could show that factors related
both to the preoperative clinical status of the patients and to
operative and CPB features can affect the occurrence of
major neurological complications; age at intervention,
previous vascular surgery, previous neurological episodes,
as well as longer CPB times were risk factors for adverse
neurological outcomes of adult cardiac surgery patients, as
previously described [13].
In addition, our study documented that the use of a centri-
fugal pump can reduce the rates of the two most feared
neurological complications of routine adult cardiac surgery
performed with the use of CPB; univariate and multivariate
analyses documented its protective effect, for the occur-
rence of both perioperative permanent neurological de®cit
and perioperative coma, reducing the risk reduction for the
considered events by approximately half (multivariable ORs
of 0.57 and 0.46 for perioperative permanent neurological
de®cit and perioperative coma, respectively).
Interestingly, the protective effect of centrifugal pump
use could be documented even if there was a clear selection
bias between the two pump types in our patient population,
and centrifugal pumps were preferred, as previously stated,
for cases with longer perfusion times. Also, the subgroup
analysis comparing preoperative and operative variables by
the type of pump could con®rm that patients operated with
centrifugal pumps, aside from the expected longer aortic
cross-clamp and CPB times, also had an increased risk
pro®le for the considered events, being more frequently
redos, insulin-dependent diabetics, and having a higher
rate of pre-existing neurological events; in fact, all of
these three factors were previously documented as risk
factors for unfavorable neurological outcome [2].
The hypothesis to explain the protective effect of the
centrifugal pumps used for CPB is, that with centrifugal
pumps, the embolic load to the brain is lower [22], as was
previously demonstrated with ultrasonic microbubble detec-
tion in the arterial CPB line [25].
On the other hand, the potential neurological bene®t of
the use of a centrifugal pump for perfusion was not paral-
leled by a decrease in in-hospital mortality; this ®nding has
no clear explanation to us, and further investigations will be
needed to clarify this point.
In conclusion, this study, with the limits of a retrospec-
tive, non-randomized study, suggests that centrifugal pump
use during routine adult cardiac surgery reduced periopera-
tive permanent neurological de®cit and coma rates. Prospec-
tive, multi-institutional, randomized studies will be needed
to better de®ne the possible protective effects of centrifugal
pumps on neurological outcomes of adult cardiac surgery.
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